addS

Thursday, 1 August 2013

Research Report on Global and China Monoclonal Antibody Industry, 2013-2017

Antibody drugs are usually generated from monoclonal antibody through genetic engineering, with the advantages of strong targeting, few side effects, etc. With rather promising application prospect in clinic treatment, antibody drugs are mainly applied in curing diseases like tumour, immune system and so on. In terms of the global market, antibody drugs account for over 40% of the entire biotech drug market and the market share still keeps increasing. Antibody drugs have become one of the most important parts of biotech drugs and monoclonal antibody drugs are even star products of antibody drugs. Among the top 10 best selling drugs in 2012, six of them were monoclonal antibody drugs with each annual sales value exceeding USD 5 billion.




In recent years, the market scale of monoclonal antibody drugs increased rapidly. In 2012, the global sales value of monoclonal antibody preparation exceeded USD 50 billion. Among that, Roche (plus Genentech) was the leading monoclonal antibody enterprises, which possessed seven products sold in the market including Avastin, Herceptin, Rituximab, etc. In 2012, its sales value of monoclonal antibody products reached USD 20 billion. Mono antibody drugs will become the main force promoting the development of biological drugs in the next few years.


To Buy A Copy Of This Report Visit :  http://www.marketresearchreports.biz/analysis/172373


In recent years, China bio pharmaceuticals industry develops rapidly, but antibody drugs lag far behind the average international level with sales value being less than 3% of biological drug share. At present, China antibody drug market is still in the initial stage. However, with Shanghai CITIC National Health Pharmaceutical Co., Ltd. and Biotech Pharmaceutical Co., Ltd. releasing humanization products, product types of domestic antibody drugs will enter the upgrading stage. Although domestic full humanization products have not been released, humanization products and full humanization products will become the domestic trend of monoclonal antibody products in the future.


Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948

Challenges and Opportunities in the Renal Denervation Market


Hypertension: Prevalence and Significance

Hypertension is one of the most preventable causes of premature morbidity and mortality globally. It is a major risk factor for stroke, myocardial infarction, heart failure, chronic kidney disease, peripheral vascular disease, cognitive decline, damage to retinal blood vessels and visual impairment, and premature death. Therefore, reducing hypertension can lower the incidence of these conditions, helping to improve the health of the population and reducing the high burdens that they place on global healthcare systems.




Renal denervation therapy involves a surgical procedure and is therefore a last resort in the treatment of hypertension. It is only considered when cheaper, simpler and potentially safer alternatives such as lifestyle modifications and the use of pharmaceuticals have failed. These patients are termed as having treatment-resistant hypertension.


To Buy A Copy Of This Report Visit :  http://www.marketresearchreports.biz/analysis/172371


Current Trends and Future Opportunities

With renal denervation technology only having been in development since the late 1990s and commercially-available since 2010, the market is in its infancy. The products remain unapproved in the US and Japan, and reimbursement is not yet widely available in other regions. Despite being an emerging market, renal denervation has sparked considerable interest due to the good safety and efficacy results it has achieved so far in helping to reduce treatment-resistant hypertension. The expectation is that renal denervation could become a multi-billion dollar market in the future. However, the success of any new medical technology is dependent on regulatory approval and reimbursement; acceptance and awareness from the medical community; and evidence of safety, efficacy and cost-effectiveness. All of these elements must be in place for the market to realise its potential.

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948

High Voltage DC Power Supply Industry in China, 2013-2017

With the development of power electronics technology and the emergence of new high-performance, high withstanding voltage and high-frequency power electronic devices, high voltage DC power supply is widely applied in industry, agriculture, health care, defense and scientific research, such as: X-ray tube, bone density testing, analytical instruments, electrophoresis, semiconductors, ion implantation, lithography, non-destructive testing, X-ray imaging, electrostatic dust removal, lampblack purification, electrostatic spraying, CT machines, laser equipment, ozone equipment, etc.




At present, technological gap between domestic high voltage power supply products and that in foreign countries still exist; a large quantity of core devices had to rely on imports so as to guarantee the products quality.


To Buy A Copy Of This Report Visit :  http://www.marketresearchreports.biz/analysis/172014


The survey of Huidian Research shows that since 2008, with the widening of the application areas, HVDC power supply showed a rapid growth rate; the average annual growth rate was higher than 60%. Impacted by the macro environment in 2012, the growth speed was slowed down; the sales volume was 160,000 units, up 33% YoY; the sales revenue was CNY 1.8 billion, up 38% YoY. Because the quality of the domestic core devices is relatively poor, a large number of products are imported from foreign counties; the imported products account for about 1/3 of the market share currently. 

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948

Wednesday, 31 July 2013

Latest Release On Publicis Omnicom Group vs. Google, Facebook, and others in Digital Advertising

The global advertising market is expected to reach approximately $505 B in 2013, representing a 3.5% growth rate. Digital advertising is the fastest growing segment within advertising, and within that segment, mobile is the fastest growing segment of Internet advertising with a projected 67% growth rate.


The merger of advertising giants would have more than 130,000 employees and will represent the number one advertisement firm with Omincom $14.2 B and Publicis $8.8, the combined revenue of $23B based on 2012 numbers. This surpasses the currently largest revenue producer WPP with $15.95B. Coming in at a current fourth place is Interpublic Group at $6.96B.

To Buy A Copy Of This Report Visit :  www.marketresearchreports.biz/analysis/172010

This research evaluates the proposed merger between Omnicom and Publicis including challenges, synergies, market opportunities, and recommendations for the combined company as it seeks to leverage its assets to obtain a greater stake in the digital advertising market. Recommendations include market focus, strategy, partnering, and acquisitions.



Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948

Now Available : Global Electroactive Polymers and Devices Market 2013-2018

Electroactive polymers are one of the most promising technologies. Compared to inorganic materials the versatile polymers have various attractive properties, such as being lightweight, inexpensive and easy to manufacture.Tremendous amount of research and development has led to Electroactive Polymers (EAP) that can also change size or shape when stimulated by the right external electrical activation mechanism, meaning they can convert electrical energy into mechanical energy. Especially in the actuators segment vast R&D activity can be seen for specialized applications such as medical devices and biomimetic-robotics.


Here the features of electroactive polymers are used to enable movement and generate force as well as electrically control surface properties.Haptics for consumer portable touch screen devices and peripherals is going to be the next big application and potentially the first large-scale implementation of EAP actuators in general with an expected penetration of 60% for haptic feedback in mobile phones for 2018.Today, EAPs are available that produce large strains and show great potential for applications. In comparision to only small response in the early development years electroactive polymers show significant deformation in the range of two to three orders of magnitude.Until now, despite several decades of R&D and first applications, the EAP field is far from mature and several subjects, such as perfomance and long-term stability, still need further development to tailor the properties of these polymers to the requirements of each application.The large-scale penetration of the touchscreen market will finally take the technology to the next level.

To Buy A Copy Of This Report Visit :  www.marketresearchreports.biz/analysis/172011

IDTechEx forcasts a penetration of the haptics for consumer electronics touch display market exceeding 60% by 2018. This success will account for over 40% of the expected total revenue in 5 years.Other applications with great potential in +5 years from now include energy harvesting from see waves, medical applications, both invasive and non-invasive, large-area sensors, speakers etc. Especially for energy harvesting and the medical sector the technology needs to prove its suitability and improve efficiency as well as long-term stability before it can finally become commercial.ive year forecasts 2013-2018


Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948

Latest Release On Global and China MRI Industry 2013 Market Research Report

The report firstly introduced MRI basic information included MRI definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, MRI industry policy and plan, MRI product specification, manufacturing process, product cost structure etc.




Then statistics China key manufacturers MRI capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers MRI products customers application capacity market position company contact information etc company related information, then collect all these manufacturers data and listed China MRI capacity production capacity market share production market share supply demand shortage import export consumption etc data statistics, and then introduced China MRI 2009-2013 capacity production price cost profit production value gross margin etc information. And also listed MRI upstream raw materials equipments and Down stream clients alternative products survey analysis and MRI marketing channels industry development trend and proposals.

In the end, this report introduced MRI new project SWOT analysis Investment feasibility analysis investment return analysis and also give related research conclusions and development trend analysis of China MRI industry. In a word, it was a depth research report on China MRI industry. And thanks to the support and assistance from MRI industry chain related technical experts and marketing engineers during Research Team survey and interviews.


Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948

Construction in South Korea - Key Trends and Opportunities to 2017: MarketResearchReports.biz

This report provides detailed market analysis, information and insights into the South Korean construction market, including:

  • The South Korean construction market’s growth prospects by sector, project type and type of construction activity
  • Analysis of equipment, material and service costs across each project type within South Korea
  • Critical insight into the impact of industry trends and issues and the risks and opportunities they present to participants in the South Korean construction market
  • Assessment of the competitive forces facing the construction industry in South Korea and profiles of the leading players
  • Data highlights of the largest construction projects in South Korea





Executive summary

The South Korean construction industry recorded a review-period (2008−2012) CAGR of 1.58%. The housing market deflated in 2008 as interest rates began to rise and banks tightened their lending conditions. This was a key reason for a decline in domestic demand, and contributed to the country’s economic deceleration from an average of 5.2% during 2000−2007 to 2.3% in 2008, and just 0.3% in 2009. Infrastructure investments will support the construction industry, which is struggling due to poor property sales and tightening credit conditions. Investments related to the 2018 Winter Olympic Games are also expected to drive industry growth. Timetric expects the South Korean construction industry to record a forecast-period (2012−2017) CAGR of 3.07%.



To Buy A Copy Of This Report Visit :  http://www.marketresearchreports.biz/analysis/172001  


Scope

This report provides a comprehensive analysis of the construction industry in South Korea:

  • Historical (2008-2012) and forecast (2013-2017) valuations of the construction market in South Korea using the construction output and value-add methods
  • Segmentation by sector (commercial, industrial, infrastructure, institutional and residential) and by project type
  • Breakdown of values within each project type, by type of activity (new construction, repair and maintenance, refurbishment and demolition) and by type of cost (materials, equipment and services)
  • Analysis of key construction industry issues, including regulation, cost management, funding and pricing
  • Assessment of the competitive environment using Porter’s Five Forces
  • Detailed profiles of the leading construction companies in South Korea

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948